Evidence map›Paper›PMID 37896983›Full record

ArticleVaccines2023

Factors Associated with COVID-19 Vaccine Uptake among Schoolgoing Adolescent Girls and Young Women in South Africa.

Kate Bergh, Kim Jonas, Zoe Duby, Darshini Govindasamy, Catherine Mathews, Tarylee Reddy, Nevilene Slingers, Granville Whittle, Fareed Abdullah

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kate BerghHealth Systems Research Unit, South African Medical Research Council, Cape Town 7501, South Africa.
Kim JonasHealth Systems Research Unit, South African Medical Research Council, Cape Town 7501, South Africa.ORCID 0000-0002-4469-6674
Zoe DubyHealth Systems Research Unit, South African Medical Research Council, Cape Town 7501, South Africa.
Darshini GovindasamyHealth Systems Research Unit, South African Medical Research Council, Cape Town 7501, South Africa.
Catherine MathewsHealth Systems Research Unit, South African Medical Research Council, Cape Town 7501, South Africa.
Tarylee ReddyBiostatistics Research Unit, South African Medical Research Council, Durban 4091, South Africa.
Nevilene SlingersOffice of AIDS and TB Research, South African Medical Research Council, Pretoria 0001, South Africa.
Granville WhittleDepartment of Basic Education, Government of South Africa, Pretoria 0001, South Africa.
Fareed AbdullahOffice of AIDS and TB Research, South African Medical Research Council, Pretoria 0001, South Africa.ORCID 0000-0002-1118-9430
South African Medical Research Council · ZAGovernment of South Africa · ZA

Funding

AIDS Foundation of South Africa None
6 · The paper itself

Abstract

(1) Background: By October 2022, vaccination rates with at least one dose of a COVID-19 vaccine were low among adolescent girls aged 12-17 (38%) and young women aged 18-34 (45%) in South Africa. This study aimed to measure and identify barriers to and facilitators of motivation to take up, access to, and uptake of COVID-19 vaccines among schoolgoing adolescent girls and young women in two districts in South Africa. (2) Methods: Using the theory of the HIV prevention cascade, we conceptualised the relationship between motivation, access, and uptake of COVID-19 vaccines, and associated barriers. Potential barriers and facilitators were identified using bivariate and multivariable Poisson regression. (3) Results: Among all 2375 participants, access was high (69%), but motivation (49%) and vaccination with at least one COVID-19 vaccine (45%) were lower. Fear of injections was a barrier to vaccine uptake (aRR 0.85 95% CI 0.82-0.88), while being tested for COVID-19 (aRR 2.10 95% CI 1.85-2.38) and believing that the COVID-19 vaccine was safe (aRR 1.31 95% CI 1.18-1.44) and would prevent you from getting very sick (aRR 1.11 95% CI 1.04-1.19) were facilitators. (4) Conclusions: The controversy about the value of vaccinating adolescents and the delay in vaccine rollout for adolescents and young adults may have contributed to fears about the safety and efficacy of COVID-19 vaccines, as well as a lack of motivation to get vaccinated.

Indexed as

adolescent girls and young womenCOVID-19 vaccinationprevention cascadesSouth Africa

Identifiers

PMID37896983
PMCPMC10610973
OpenAlexW4387540439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.